Dow Up 0.76% Nasdaq Up 0.69%

Novo Nordisk A/S (NVO)

-NYSE
45.77 Up 0.05(0.11%) Oct 24, 4:02PM EDT
|After Hours : 45.77 0.00 (0.00%) Oct 24, 5:17PM EDT
Prev Close:45.72
Open:45.68
Bid:45.40 x 500
Ask:47.00 x 200
1y Target Est:49.37
Beta:0.8
Next Earnings Date:N/A
Day's Range:44.91 - 45.84
52wk Range:33.04 - 49.11
Volume:3,939,307
Avg Vol (3m):1,139,920
Market Cap:120.32B
P/E (ttm):27.51
EPS (ttm):1.66
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 0.11%120.32B
LLYUp 2.64%70.79B
PFEUp 1.78%184.58B
SNYUp 0.92%141.76B

Key Statistics

Forward P/E (1 yr):23.00
P/S (ttm):8.36
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.77
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback